- James A. Thomson, Thomas M. Palay, Robert J. Palay, Igor Slukvin, Timothy J. Kamp, Craig T. January
- Madison, WI
- Went Public on Jul 25, 2013
- Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.
Cellular Dynamics International, Inc. develops stem cell technologies for drug development and personalized medicine applications. It offers drug screening and toxicity testing products based on induced pluripotent stem (iPS) cell technology. The company also provides cardiac toxicity drug testing services, including GLP and non-GLP hERG electrophysiological assays, as well as action potential and cytotoxicity screens using cardiomycytes. In addition, it offers pluripotent stem cell derived products, including cardiomyocytes, hematopoietic cells, neural cells, and hepatocytes. Cellular Dynamics International, Inc. was formerly known as iPS Cells Inc. and changed its name to Cellular Dynamics International, Inc. in July 2008. The company was founded in 2004 and is based in Madison, Wisconsin.
Current Team (14)Update
Founder, Chief Scientific Officer & Board of Directors
Vice President of Research and Development, Manufacturing and Quality Systems and Chief Operating Officer
Chairman of the Board and Chief Executive Officer, Founders & Board of Directors
Vice President and Chief Technology Officer
Vice Chairman of the Board and President, Founders & Board of Directors
Funding Rounds (4) - $111.6MUpdate
Board Members and Advisors (4)Update
525 Science Drive
Madison, WI 53711
- 07/25/13 -nasdaq.com